Innoviva Analyst Price Targets - Benzinga

Innoviva Inc

INVANASDAQ

Trade with Public

Trade with Public

$21.08

0.301.44%

Últ. Act.: Oct 19, 4:00 PM

$21.08

0.301.44%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Innoviva Analyst Price Targets

Wall Street analyst price targets and consensus rating for Innoviva (INVA).

Price Target Range — 6 Quarters

Analyst Consensus — 5 Analysts

4Buy

1Sell

Consensus RatingBuy# Analysts5Avg. Consensus PT$38Upside to Avg. PT+78.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	Oppenheimer	Les Sulewski	Assumes	Outperform	$35
Aug 7, 2026	Cantor Fitzgerald	Steve Seedhouse	PT Cut	Overweight	$36→$34
Jun 22, 2026	BTIG	Julian Harrison	Maintained	Buy	$42
Jun 1, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$46
May 26, 2026	BTIG	Julian Harrison	Maintained	Buy	$42
May 7, 2026	BTIG	Julian Harrison	PT Raise	Buy	$35→$42
Feb 26, 2026	BTIG	Julian Harrison	Maintained	Buy	$35
Feb 17, 2026	BTIG	Julian Harrison	Initiate	Buy	$35
Dec 16, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$45→$46
Nov 6, 2025	Cantor Fitzgerald	Steve Seedhouse	PT Raise	Overweight	$29→$31
Sep 30, 2025	Goldman Sachs	Asad Haider	Initiate	Sell	$17
Aug 11, 2025	Oppenheimer	Trevor Allred	Initiate	Outperform	$35
Aug 11, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$40→$45
Jul 14, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$40
Jul 11, 2025	Cantor Fitzgerald	Steve Seedhouse	Initiate	Overweight	$26
Mar 7, 2025	Scotiabank	Louise Chen	Initiate	Sector Outperform	$55
Aug 1, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jul 30, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jun 20, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Jun 18, 2024	Cantor Fitzgerald	Louise Chen	Initiate	Overweight	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

Oppenheimer analyst Les Sulewski assumes Innoviva (NASDAQ:INVA) with a Outperform rating and announces Price Target of $35.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Innoviva, Lowers Price Target to $34

Cantor Fitzgerald analyst Steve Seedhouse maintains Innoviva (NASDAQ:INVA) with a Overweight and lowers the price target from $36 to $34.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $46 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Innoviva, Maintains $42 Price Target

BTIG analyst Julian Harrison reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $42 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Innoviva, Raises Price Target to $42

BTIG analyst Julian Harrison maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $35 to $42.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Innoviva, Maintains $35 Price Target

BTIG analyst Julian Harrison reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $35 price target.

Benzinga Newsdesk